According to FutureWise analysis the market for Blood Transfusion in 2023 is US$ 4.66 billion, and is expected to reach US$ 7.45 billion by 2031 at a CAGR of 6.00%.

As of 2024, the global blood transfusion market is valued at approximately USD 7.8 billion, with projections indicating a significant increase, expecting to reach around USD 13.6 billion by 2034. This represents a compound annual growth rate (CAGR) of about 6.3% over the period from 2024 to 2034. Several key factors are driving this upward trend. Firstly, there is a notable rise in the number of surgical procedures being performed globally, which increases the need for blood transfusions. Additionally, the prevalence of trauma cases continues to grow, necessitating timely access to blood supplies. Chronic diseases, such as cancer and autoimmune disorders, also contribute to the demand for transfusions, as patients often require blood products during treatment. Moreover, the expanding healthcare infrastructure, particularly in emerging economies, plays a crucial role in enhancing the capacity for blood collection and storage. Advances in medical technology and a stronger emphasis on blood safety are also pivotal, as healthcare providers seek to implement more efficient transfusion practices. Overall, the combination of these factors creates a promising outlook for the blood transfusion market in the coming decade.

FutureWise Market Research has released a report that provides an intricate analysis of Blood Transfusion Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

Request a Free Sample @

https://www.futurewiseresearch.com/contact.aspx?rpt=9639&type=requestsample

Blood Transfusion Market Segmentation:

By Product

• Consumables and supplies
• Blood bag and accessories
• Blood mixer
• Fridge and freezer
• Filter
• Inline filter
• Dockable filter
• Blood component separator
• Apheresis devices
• Pathogen reduction system
• Others

By End User

• Laboratory
• Ambulatory Surgical centers
• Hospitals
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Blood Transfusion Market:

• Abbott
• Becton Dickinson
• B Braun
• Fresenius Kabi
• Haemonetics Corporation
• Immucor
• Kidde-Fenwal
• Macopharma
• Terumo Corporation
• Grifols S.A
• Cerus Corporation

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=9639&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Blood Transfusion Market By Product, By End User and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com